Navigation Links
Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease
Date:12/1/2011

to recognize the need to inject CERE-120 directly into the substantia nigra, thus reducing dependency on retrograde transport."  Additionally, because of the safety record thus far established with CERE-120, the current Phase 2b study injected a 4-fold higher CERE-120 dose into the putamen, compared to prior studies.  "These dosing changes are intended to help assure that the entire degenerating neuron is exposed to sufficient neurotrophic factor, stimulating a more robust neurotrophic response, which in turn, should further enhance and accelerate neuronal repair and clinical benefit," continued Dr. Bartus. 

Ceregene's previous Phase 2a clinical study of CERE-120 demonstrated "proof of concept", showing efficacy on a number of secondary clinical motor and quality of endpoints, with no measurement similarly favoring the sham control treatment.  While that study missed the primary endpoint at 12 months post treatment, a statistically significant improvement from CERE-120 was seen on this measure at 15 and 18 months, post treatment (p=0.023).  Moreover, even more secondary endpoints showed benefit at these longer, post-treatment time points.  The current Phase 2b study will analyze patient outcomes following 15 to 24 months post treatment.  The primary endpoint in both Phase 2 trials is the "UPDRS off" score which is a measure of motor function commonly used in clinical trials of Parkinson's disease.  Ceregene expects to report data from the new Phase 2b study near the end of the first quarter of 2013.

This and prior CERE-120 clinical studies were partially supported by a series of generous grants from the Michael J. Fox Foundation for Parkinson's Disease Research.  Participating Medical Centers included The University of California, San Francisco; Emory University; Baylor College of Medicine; Duke University Medical Center; University of Alabama, Birmingham; Stanford University School of Medicine; The Unive
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinsons Disease
2. Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinsons Disease
3. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
4. ETCs Aircrew Training Systems Completes Factory Acceptance Tests for Highly Advanced Suite of Training Equipment for the Republic of Korea Air Force Aeromedical Center
5. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
6. Par Pharmaceutical Completes Acquisition of Anchen
7. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
8. New Spot Vision Screener Completes School Screening in Less Than Two Hours
9. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
10. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
11. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... DIEGO , Oct. 1, 2014 ... molecular diagnostics, announced today that Eli Diamond ... Kettering Cancer Center (MSK), presented clinical data from ... precision cancer monitoring platform for the determination of ... a liquid biopsy.  The results were presented to ...
(Date:10/1/2014)... Oct. 1, 2014   Royal Philips ... announced its eCareCoordinator and eCareCompanion telehealth applications have ... Drug Administration (FDA). A part of Philips Hospital ... eCareCoordinator and eCareCompanion are focused on patient care ... applications to be available through the cloud-based digital ...
(Date:10/1/2014)... Switzerland , October 1, 2014 ... Genomics and Next Generation Sequencing (NGS) data analysis, today ... run full cystic fibrosis analysis in a single NGS ... characterisation of all types of variants in a single ... Until now, it has not been possible to simultaneously ...
Breaking Medicine Technology:Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 4Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... heart organizations representing cardiologists and cardiothoracic surgeons released ... aortic valve replacement (TAVR) programs. The recommendations are ... aortic stenosis, a form of valvular heart disease, ... Since the Food and Drug ...
... Calif., March 1, 2012  Heritage Provider Network presented checks ... Heritage Health Prize competition at the Strata Conference in ... the 12 month mark. Once again, ... competition, winning the top spot.  Players include David Vogel, ...
Cached Medicine Technology:Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 2Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 3Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 4Leading Cardiovascular Organizations Release Credentialing Recommendations for Heart Valve Replacement Procedure 5Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3
(Date:10/1/2014)... of scientists has shown that more than 80 per ... drugs. , The study found that medicines called ,JAK ... genetic mutation that is present in more than 80 ... currently used, or are in clinical trials, for diseases ... , Bowel cancer is the second-most common cancer in ...
(Date:10/1/2014)... a policy focus on expanding access to care ... continues to have significant dental disease. In this ... American Dental Association , researchers from Tufts University ... Dental Medicine report on the first large-scale survey ... by caregivers to adults with developmental disabilities. The ...
(Date:10/1/2014)... Hills, CA (PRWEB) October 01, 2014 ... internationally-franchised Fit Body Boot Camp fitness boot camps, he’s ... selling personal training , with sold out business summits, ... stint as marketing consultant to a recent Spike TV ... Keuilian says that now is the time for personal ...
(Date:10/1/2014)... October 01, 2014 Farmington Company ... a redefined mission and visual identity helping brokers, ... partnering with them to create greater benefit communication ... that focuses on empowering customers to better leverage ... The crown jewel of the rebrand is the ...
(Date:10/1/2014)... Jupiter, FL (PRWEB) October 01, 2014 ... Begley, Jr., scheduled to broadcast on Monday, October 20, ... In this episode, Innovations will go behind the scenes ... prevention programs. This segment will explore the practical help ... young adults, which teaches the warning signs of abuse, ...
Breaking Medicine News(10 mins):Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... offering Indian companies the opportunity to attend New Frontiers 2007, ... seeks to help international companies that are keen to expand ... business and understanding of the market. ... 7th of March 2007, will be the largest gathering of ...
... severe nerve pain – by aiming drugs at a previously ... Utah scientists who study the venoms of deadly, sea-dwelling cone ... a chronic and debilitating form of pain suffered by hundreds ... a University of Utah research professor of biology, and research ...
... narrowing of the arteries, due to deposition of substances ... time, the plaque build–up may block the blood flowing ... ,But, Canadian researcher Dr. Sanaz Piran and ... presented a report on the early onset of atherosclerosis ...
... cancer prevention has advanced to the point where researchers are ... and treat cancer. The// Researchers now say they can detect ... the presence of two proteins in men they say will ... ,All of these novel findings need much more ...
... to evaluate the support available to the estimated 200 ... disease. Taking// cognizance of the burgeoning malady, the theme ... disadvantaged and the vulnerable’ amply reflects the cardinal purpose ... in diabetes management seeks to draw attention towards the ...
... anti-TNF therapy that has FDA approval for treating ... children with juvenile rheumatoid// arthritis, according to research ... Rheumatology Annual Scientific Meeting in Washington, DC. ... adults with moderate to severe rheumatoid arthritis, targets ...
Cached Medicine News:Health News:A Hot Date with the Lucrative UK Pharma Market 2Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 2Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 3Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 4Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 5Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 6Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 7Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 8Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 9Health News:A Novel Technique That Detects "Cancer Genes" From The Breath Of Smokers 10Health News:The Holy Grail of Diabetes Management 2Health News:The Holy Grail of Diabetes Management 3Health News:Adalimumab Proves Effective for Children with Juvenile Rheumatoid Arthritis 2
Inquire...
Inquire...
Inquire...
Inquire...
Medicine Products: